Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

LONDON MARKET OPEN: Mixed start in Europe; Rolls-Royce shares climb
26 Feb 2026

LONDON MARKET OPEN: Mixed start in Europe; Rolls-Royce shares climb

(Alliance News) - European stocks were mixed in early dealings on Thursday, with markets awaiting a fresh set of catalysts after Nvidia beat on earnin...

LONDON MARKET CLOSE: HSBC reclaims top spot as FTSE 100 hits new high
25 Feb 2026

LONDON MARKET CLOSE: HSBC reclaims top spot as FTSE 100 hits new high

(Alliance News) - The FTSE 100 reached fresh heights on Wednesday, with well-received results from HSBC, and gains in mining stocks, paving the way fo...

Avacta hails new data supporting proprietary preCision platform
24 Feb 2026

Avacta hails new data supporting proprietary preCision platform

(Alliance News) - Avacta Group PLC on Tuesday saw its shares rise, as it said new data demonstrates a favourable delivery profile and advantages of it...

LONDON MARKET OPEN: Stocks fall after latest tariff salvo
23 Feb 2026

LONDON MARKET OPEN: Stocks fall after latest tariff salvo

(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertai...

US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment
20 Feb 2026

US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment

(Alliance News) - AbbVie Inc and AstraZeneca PLC on Friday hailed a regulatory win for their joint cancer treatment programme.

AstraZeneca's Calquence leukaemia treatment gets US FDA approval
20 Feb 2026

AstraZeneca's Calquence leukaemia treatment gets US FDA approval

(Sharecast News) - AstraZeneca said on Friday that the US Food and Drug Administration has approved its 'Calquence', or acalabrutinib, in combination ...

LONDON BROKER RATINGS: Three brokers cut Unilever to 'hold' from 'buy'
18 Feb 2026

LONDON BROKER RATINGS: Three brokers cut Unilever to 'hold' from 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever
16 Feb 2026

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: